Havertown, PA, United States of America

E James Delikatny

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: E James Delikatny: Innovator in Radiographic Contrast Agents

Introduction

E James Delikatny is a notable inventor based in Havertown, PA (US). He has made significant contributions to the field of medical imaging, particularly in the development of radiographic contrast agents. With a total of 2 patents, his work has advanced the capabilities of x-ray imaging technologies.

Latest Patents

Delikatny's latest patents include innovative methods and materials for enhancing x-ray imaging. One of his patents focuses on radiographic contrast agents for temporal subtraction and dual-energy x-ray imaging. This invention includes stabilized metal nanoparticles and encapsulated nanoparticles, along with methods for imaging tissue using these agents. Another significant patent is directed towards the vivo detection of phospholipase activation. This invention features a phospholipid-based NIR molecular beacon, which includes a phospholipid moiety and an NIR fluorophore moiety linked to a phospholipid glycerol backbone. It also provides methods for analyzing samples for phospholipase presence and activity in vivo.

Career Highlights

Delikatny is affiliated with the University of Pennsylvania, where he continues to contribute to research and innovation in medical imaging. His work has been instrumental in developing new technologies that improve diagnostic capabilities in healthcare.

Collaborations

Some of his notable coworkers include Anatoliy V Popov and Andrew D A Maidment. Their collaborative efforts have further enhanced the research and development of advanced imaging techniques.

Conclusion

E James Delikatny's contributions to the field of radiographic contrast agents exemplify the impact of innovation in medical imaging. His patents reflect a commitment to improving diagnostic methods, ultimately benefiting patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…